Myocardial infarct imaging of antibodies to canine cardiac myosin with indium-111-diethylenetriamine pentaacetic acid.
Antibodies, by virtue of marked selectivity and affinity, may lend themselves to identification of structures of unique antigenic specificity in vivo. In experimental myocardial infarction in dogs, F(ab')2 fragments of antibodies to cardiac myosin that had been labeled with iodine-131 were shown to localize within the lesion. Because the energy characteristics of iodine isotopes are not ideal for imaging with a gamma camera, a new method for labeling antibody fragments with divalent or polyvalent radionuclides was developed. A bifunctional chelating agent, diethylenetriamine pentaacetic acid was covalently coupled, by an amide bond, to Fab fragments of antibodies to canine cardiac myosin. A stable chelate was then formed with indium-111, a nuclide that has appropriate half-life and energy characteristics for gamma imaging. Antibodies treated in this way retain their antigen-binding activity and are useful in locating myocardial infarcts in vivo.
D000818:Animals; D000906:Antibodies / Q000032:analysis*; D004285:Dogs; D007140:Immunoglobulin Fab Fragments / Q000032:analysis; D007204:Indium; D009203:Myocardial Infarction / Q000378:metabolism*; D009206:Myocardium / Q000032:analysis*; D009218:Myosins / Q000032:analysis*; D011868:Radioisotopes
D000906:Antibodies; D007140:Immunoglobulin Fab Fragments; D011868:Radioisotopes; D007204:Indium; D009218:Myosins